Approval · Notice of Compliance 1098 · 2000
NORPRAMIN: Notice of Compliance 1098
Issued August 15, 2000
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1098
- Date
- August 15, 2000
- Company
- Aventis Pharma Inc.Laval, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Antidepressant
Products in this notice
Medicinal ingredients
- DESIPRAMINE HCL 10 MG per TAB
- DESIPRAMINE HCL 25 MG per TAB
- DESIPRAMINE HCL 50 MG per TAB
- DESIPRAMINE HCL 75 MG per TAB
- DESIPRAMINE HCL 100 MG per TAB
- DESIPRAMINE HCL 150 MG per TAB